Search

Your search keyword '"Asmann Y"' showing total 59 results

Search Constraints

Start Over You searched for: Author "Asmann Y" Remove constraint Author: "Asmann Y" Language english Remove constraint Language: english
59 results on '"Asmann Y"'

Search Results

1. Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways

8. MicroRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia

9. Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development

10. Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform

11. 3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer

12. GLOSSI: a method to assess the association of genetic loci-sets with complex diseases

16. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

17. Predictive genomic markers to chemotherapy and adjuvant trastuzumab via whole genome expression DASL profiling in the N9831 adjuvant study.

18. Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14).

19. Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome Sequencing.

20. Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL.

21. Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL.

22. AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.

23. Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits.

24. Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL.

25. Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies.

26. Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways.

27. Managing genomic variant calling workflows with Swift/T.

28. Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study.

29. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

30. PCNT point mutations and familial intracranial aneurysms.

31. Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry.

32. Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma.

33. Lipocalin-2 protects the brain during inflammatory conditions.

34. High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.

35. Waldenstrom macroglobulinemia cells devoid of BTK C481S or CXCR4 WHIM-like mutations acquire resistance to ibrutinib through upregulation of Bcl-2 and AKT resulting in vulnerability towards venetoclax or MK2206 treatment.

36. Whole-exome analysis reveals novel somatic genomic alterations associated with cell of origin in diffuse large B-cell lymphoma.

37. BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma.

38. Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.

39. Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases.

40. Frequent occurrence of large duplications at reciprocal genomic rearrangement breakpoints in multiple myeloma and other tumors.

41. Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.

42. PPP6R3-USP6 amplification: Novel oncogenic mechanism in malignant nodular fasciitis.

43. Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma.

44. Whole exome sequencing of a patient with metastatic hidradenocarcinoma and review of the literature.

45. Analysis of COQ2 gene in multiple system atrophy.

46. Genetic diversity of newly diagnosed follicular lymphoma.

47. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.

48. Insulin fails to enhance mTOR phosphorylation, mitochondrial protein synthesis, and ATP production in human skeletal muscle without amino acid replacement.

49. Germline copy number variation and ovarian cancer survival.

50. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.

Catalog

Books, media, physical & digital resources